For The Better

You can boost your future financial security by wiping out the chance of various financial regrets.

These two companies are each worth under $4 billion, but they’re packed with potential.

Eli Lilly and Lululemon operate in very different industries, but both are on promising trajectories.

The Oracle of Omaha is a value investor at heart — and value is tough to come by at the moment.

Nvidia has some advantages over its troubled partner.

Abbott Laboratories and Johnson & Johnson both have raised their dividends annually for more than 50 years.

These dividend-paying stocks offer hard-to-find high yields, but that doesn’t necessarily make them good stocks to buy now.

Big changes could be coming to Social Security, depending on which candidate wins in November.

The foundry giant is set to spend big in the coming years, and there’s one company that could stand to win big.

Both companies benefit from the adoption of AI in the cloud, but one of them stepped up its game recently.

Despite the 2025 cost-of-living adjustment (COLA) representing a modest silver lining, inflationary pressures are liable to get the best of retirees, once again.

If you’re nearing retirement, it’s important to understand the ins and outs of Medicare. This quick primer should help.

If these tried-and-true steps aren’t already on your priority list, you may want to clear some room.